We are happy to announce the program for the 16th International Congress of the Polish Neuroscience Society! 🥳 congress2023.ptbun.org.pl/Programme2

El próximo 28 de mayo a las 16.00 h no te pierdas el seminario web Innovaciones en #Neurooncología y síndromes #paraneoplásicos organizado por Neurología HU La Paz 🧠👇

🗣️PhD thesis defense Neural Ensemble Dynamics in Multi-Option Decision-Making 📆28/05 - 16h 👨‍🔬Balma Serrano Porcar  📍 Esteve Auditorium, CEK 👉f.mtr.cool/sndsaefcfs

New issue of Brain now online! academic.oup.com/brain/issue/14…

Stridor is a common and presenting feature of IgLON5-antibody disease. This Research Letter describes an additional inspiratory noise distinct from stridor, in three patients, observed independently across two centers. ja.ma/3HkZD1y

Dr. Lidia Sabater linkedin.com/posts/prof-dr-…

Vaibhav Oberoi, M.B.B.S. The anti-IgLON5 disease ACTRIMS® Shruti Agnihotri Thank you for investigating this rare disease. I am a Canadian PhD student at the University of Waterloo in Ontario Canada. I was diagnosed with anti-iglon5 disease in April and looking to participate in studies to help find a cure or effective treatments. Thank you!

Opening ceremony XX #SENC2025 meeting in Las Palmas de Gran Canarias. Inagural lecture by Prof. Isabel Fariñas Fariñas Lab

La #microbiota intestinal 🦠 puede ayudar a predecir y potenciar la terapia #CART. 📃Un estudio del IDIBAPS y del Hospital Clínic asocia ciertos perfiles y metabolitos con mejor respuesta en #MielomaMúltiple. diariomedico.com/medicina/hemat…

The anti-IgLON5 disease Dr. Lidia Sabater Thank you so much for the invitation to promote awareness about The anti-IgLON5 disease disease in the 17th congress of International polish neuroscience society Polish Neuroscience Society

✨ Spotlight on final session at the AE & PNS Congress (Sept 18–19, Lyon) Discover the session titles in the visual below. 👉 Don’t miss it! betpsy-congres.com #Neurology #Congress

La Revuelta Defender la investigación es de ser buena gente. Y como sabemos que el La Revuelta lo sois...¿nos invitáis a que os expliquemos nuestra campaña exigiendo que se cumpla el #PactoXLaCiencia?

🆕A study led by #CLÍNIC-#IDIBAPS shows how a new CAR-T therapy can control multiple myeloma in preclinical models despite the development of resistance due to the loss of one of the usual targets of immunotherapy 👉f.mtr.cool/kpgecfreti

Thanks to French Reference Center for PNS and AE for the kind invitation to the AE and PNS Congress! A wonderful programme full of innovations in the field 🧠

Raquel Sánchez-Valle Un estudi del #CLÍNIC-#IDIBAPS ha detectat deficiències cognitives subtils en persones en estadis preclínics de la malaltia, quan encara els participants no són conscients dels primers símptomes, el que ajudaria a la detecció primerenca i al seguiment 👉f.mtr.cool/dwhgqxhtvy

🧫🩺🦠ImmunoRevolució: De la Recerca a la Medicina del Futur Aquest 🗓️divendres 26 a les 18h al 📍Cosmocaixa 👤Manel Juan, 👤Jesús Planagumà i 👤Marianna Spatola de l'#IDIBAPS participaran en aquesta cicle de xerrades sobre el poder transformador de la recerca

🧠 New study: Serum NfL and GFAP levels correlate with clinical severity—especially bulbar symptoms. Higher serum NfL also predicts 1-year mortality, independent of age.📈 Results support NfL as a biomarker for disease monitoring and prognosis. #Neurology neurology.org/doi/10.1212/NX…

OPINIÓ | El futur dels tractaments de l’esclerosi múltiple  🆕📝Columna de la Dra. Yolanda Blanco, Cap de la Unitat de Neuroimmunologia i Esclerosi Múltiple del #CLÍNIC. 💬 "Avui, la majoria de pacients poden aspirar a una vida sense discapacitat." ➕Info👉

🔊 #SaveTheDate